All In Biotech

Free tool

FAERS Monitor: Lipofen

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021612 or its brand name (Lipofen, Fenofibrate). Reports on generic versions are filed under their own applications.

Reports

35,744

Serious

24,452

68% of reports

Hospitalization

12,434

Death reported

2,830

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue2,198
  • diarrhoea2,137
  • nausea2,068
  • drug ineffective1,825
  • headache1,581
  • dyspnoea1,552
  • off label use1,415
  • dizziness1,401
  • pain1,395
  • fall1,382
  • asthenia1,331
  • acute kidney injury1,282
  • vomiting1,240
  • arthralgia1,199
  • pruritus1,172

Reports by year received

View as table
YearReports
2004264
2005251
2006397
2007300
2008474
2009564
2010677
2011981
20121,105
20131,062
20141,370
20152,187
20162,574
20172,504
20182,793
20192,719
20202,495
20212,265
20222,230
20232,161
20242,070
20252,334
20261,967

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,018,415 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
acute kidney injurySignal1,2825.04.74,048
fallSignal1,3822.42.31,198
astheniaSignal1,3312.12.0763
diarrhoea2,1372.01.91,018
pruritus1,1721.81.7420
arthralgia1,1991.71.6350
fatigue2,1981.71.6601
dizziness1,4011.71.6370
dyspnoea1,5521.61.5372
vomiting1,2401.61.5249
nausea2,0681.51.5404
headache1,5811.51.4257
pain1,3951.31.3121
off label use1,4151.00.94
drug ineffective1,8250.80.882

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.